Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 13 posts of 823 posts found.

Novartis appoints Reinhardt as chief operating officer

October 24, 2008
Sales and Marketing Novartis

Novartis has shaken up its senior management structure with the creation of a new post – chief operating officer. From …

News

Working in vaccines, a primer

October 22, 2008
Business Services, Research and Development, Sales and Marketing Novartis, recruitment, vaccines

Feature

Osteoporosis drug Aclasta approved for use in men

October 2, 2008
Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

News

Novartis’ European chief says ‘Geotailoring’ will speed decision making and bring it closer to customers

January 28, 2008
Sales and Marketing Eric Cornut, Novartis

Q: Europe’s biggest market Germany is preparing for some major reforms at the moment. How is Novartis responding to that …

News

Jimenez aims for savings and marketing rejuvenation

January 28, 2008
Sales and Marketing Jimenez, Jiminez, Novartis

The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …

News

Novartis changes pharma management after weak third quarter

October 19, 2007
Sales and Marketing Novartis

Novartis has switched the heads of its consumer and pharmaceuticals divisions as part of a wider reorganisation of its pharma …

News

Indian court dismisses Novartis patent claim

August 8, 2007
Sales and Marketing India, Novartis

Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …

News

Latest news from Datamonitor

June 22, 2007
Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …

News

Lucentis approved in Europe

January 26, 2007
Sales and Marketing Lucentis, Novartis

European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …

News

New blindness treatment moves closer to market

November 28, 2006
Sales and Marketing AMD, Lucentis, Novartis

Patients suffering from the leading cause of blindness could soon benefit from a new treatment after it gained preliminary approval …

News

Novartis to be first pharma to conduct R&D in China

November 7, 2006
Research and Development Asia, China, Novartis, em

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …

News

New Novartis blindness treatment filed in Europe

March 2, 2006
Sales and Marketing AMD, Lucentis, Novartis

Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …

News

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006
Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

News
The Gateway to Local Adoption Series

Latest content

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026